Ximelagatran or warfarin in atrial fibrillation?

Lancet. 2004 Feb 28;363(9410):735-6; author reply 736. doi: 10.1016/S0140-6736(04)15678-X.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Anticoagulants / therapeutic use*
  • Aspirin / therapeutic use
  • Atrial Fibrillation / drug therapy*
  • Azetidines / therapeutic use*
  • Benzylamines
  • Humans
  • Randomized Controlled Trials as Topic / standards
  • Research Design / standards
  • Stroke / prevention & control
  • Thromboembolism / prevention & control
  • Treatment Outcome
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Azetidines
  • Benzylamines
  • ximelagatran
  • Warfarin
  • Aspirin